Paula G. O’Connor

SVP, Clinical Development at Nurix

Paula G. O’Connor, M.D., has served as the Senior Vice President of Clinical Development since September 2022. Dr. O’Connor is trained as a hematologist-oncologist with more than 15 years of drug development expertise. Prior to joining Nurix, Dr. O’Connor held senior level positions in Clinical Development and Medical Affairs at Protagonist Therapeutics, Oncopeptides, Inc., Coherus Biosciences, Medivation, Onyx, and Genentech. Dr. O’Connor completed her fellowships in Hematology, Oncology, and AIDS Oncology at the combined programs of the Massachusetts General, Brigham and Women’s, and Dana Farber Cancer Institute.

She holds a B.A. in Psychology-Biology from Yale University and an M.D. from Stanford University.

Location

San Francisco, United States

Links


Org chart


Teams


Offices


Nurix

3 followers

Nurix Therapeutics discovers drugs that harness the body's natural process to control protein levels. Nurix is focused on developing drugs to treat cancer including the novel, small molecule immuno-oncology agents.


Industries

Employees

201-500

Links